Stock Market Today, June: AbbVie Cash Offer Boosts Apogee
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
A straightforward take on whether SP 500 or balanced funds fit better for retirement, covering growth potential, risk, and suitability.
25,481 articlesA major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
PepsiCo reported higher revenue, yet its stock hovered near a 52-week low as investors weighed costs, margins, and gr...
Apple’s next AI chapter hinges on Siri. If the so-called this "siri-ous" problem could derail AI progress, investors ...
Richtech Robotics faced a dramatic sell-off last month as legal issues and a disappointing earnings report rattled in...
Geopolitics can tip energy costs, and that ripple reaches AI markets. Learn how the Iran conflict briefly sent oil pa...
Investors are asking if this lucid make investors wealthier. The answer lies in Lucid's disciplined path to scale, ma...
Investors have watched Micron stock keep going lower despite upbeat earnings. This deep dive explains the forces behi...
How did xplr (xifr) perform in Q1 2026, and what does it mean for 2026 earnings guidance? This article breaks down th...
Shoe Carnival's Q1 2026 results offer early clues about its path through promotions, online growth, and inventory man...
Intel stunned investors in 2026 with a 225% surge. This guide explores the factors behind that rally and what it coul...
A bold investment thesis hinges on the AI inference niche. After June 3, the market could reward execution as much as...
New research shows AI projects struggle to deliver ROI unless companies redesign roles, workflows, and incentives. Ex...